Europe — EMA
Oralsone Adultos (Hydrocortisone Hydrogen Succinate)
Hydrocortisone hydrogen succinate, the active ingredient in Oralsone Adultos, is a glucocorticoid presented as a oral tablet for systemic use.
Request sourcing
What is Hydrocortisone Hydrogen Succinate?
Hydrocortisone hydrogen succinate, the active ingredient in Oralsone Adultos, is a glucocorticoid presented as a oral tablet for systemic use. It is employed to manage inflammatory and autoimmune conditions in adult patients. GNH USA supplies Oralsone Adultos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Oralsone Adultos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Hydrocortisone Hydrogen Succinate used for?
Hydrocortisone hydrogen succinate is a glucocorticoid that modulates inflammatory and immune pathways. - Rheumatoid arthritis: reduces inflammation and joint pain, improving mobility. - Systemic lupus erythematosus: controls disease flares and organ inflammation. - Severe allergic reactions: diminishes systemic allergic response and airway swelling. - Acute adrenal insufficiency: provides rapid glucocorticoid replacement. - Dermatologic autoimmune disorders: lessens skin inflammation and lesion formation. - Inflammatory bowel disease: helps reduce intestinal inflammation and related symptoms.
What are the side effects of Hydrocortisone Hydrogen Succinate?
Adverse reactions may arise from systemic glucocorticoid exposure.
Common Side Effects: - Increased appetite - Weight gain - Mood changes - Elevated blood glucose - Mild gastrointestinal discomfort - Insomnia
Serious or Rare Side Effects: - Severe infection - Osteoporosis or fractures - Peptic ulcer disease - Adrenal suppression - Psychosis or severe mood disorder - Cushing‑like syndrome
What precautions apply to Hydrocortisone Hydrogen Succinate?
When using Oralsone Adultos, consider the following safety measures: - Monitor: Regular blood glucose and blood pressure monitoring should occur. - Assess: Evaluate the patient for a history of infections or tuberculosis before treatment. - Taper: Gradual tapering is recommended when discontinuing the treatment to avoid adrenal insufficiency. - Contraindications: Avoid if the re g - Store at ambient room temperature: keep the tablet in the original pack and protect from moist g - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - ",
